PMV PHARMACEUTICALS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value
PMV PHARMACEUTICALS, INC. (PMVP) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value of $218.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue · last filed 2026-08-14
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value $218.00K.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value $83.00K.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value $86.00K.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value $417.00K.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value as first filed |
|---|---|---|
| 2026-06-30 | $218.00K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $83.00K 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $86.00K 10-K · filed 2026-03-06 | |
| 2025-09-30 | $417.00K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $28.00K 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $6.00K 10-Q · filed 2025-05-09 | |
| 2024-09-30 | $190.00K 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $231.00K 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $273.00K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $162.00K 10-K · filed 2025-03-03 | $990.00K 10-K · filed 2024-02-29 |
| 2023-09-30 | $9.94M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $11.01M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $5.61M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $17.24M 10-K · filed 2023-03-01 | |
| 2022-09-30 | $28.40M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $36.33M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $63.62M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $68.51M 10-K · filed 2022-03-01 | |
| 2021-09-30 | $94.08M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $116.31M 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $117.97M 10-Q · filed 2021-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |